Search

everythinglearnresearchcommunity

for

Search:↓

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Muse cells from human bone marrow help reduce symptoms of atopic dermatitis in mice.

Certain drugs can change hair color, either lightening or darkening it.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Baricitinib is effective and safe for treating severe alopecia areata.

Electric stimulation at 448 kHz can promote hair growth by enhancing cell activity in hair follicles.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Organoids and hair-on-chip technologies show promise for hair regeneration but face clinical challenges.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.